Biomarkers and surrogate end points in clinical trials of tuberculosis treatment
- PMID: 17624855
- DOI: 10.1086/519744
Biomarkers and surrogate end points in clinical trials of tuberculosis treatment
Comment on
-
Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis.J Infect Dis. 2007 Feb 1;195(3):357-65. doi: 10.1086/510397. Epub 2006 Dec 21. J Infect Dis. 2007. PMID: 17205474
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
